ten23 health, a global contract development and manufacturing organization (CDMO), has expanded swissfillon’s manufacturing site in Visp, canton of Valais, Switzerland, which was acquired last October.   The FDA-inspected site in Visp currently offers sterile manufacturing of pre-filled syringes, vials, and cartridges for clinical trial and market supplies. To enable further growth of its existing production capacity, ten23 health is investing in an expansion of supporting areas in an adjacent...